We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+6.99%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
AUM
$2.36B
AUM Growth
+$242M
Cap. Flow
+$106M
Cap. Flow %
4.48%
Top 10 Hldgs %
34.74%
Holding
3,215
New
294
Increased
1,348
Reduced
581
Closed
158

Sector Composition

Rank Sector Weight
1 Technology 15.92%
2 Financials 7.56%
3 Healthcare 5.92%
4 Communication Services 5.21%
5 Consumer Discretionary 4.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRTX
2876
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$1K ﹤0.01%
5
-18
-78% -$2.89K
HT
2877
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$1K ﹤0.01%
75
CCF
2878
DELISTED
Chase Corporation
CCF
$1K ﹤0.01%
14
TRHC
2879
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$1K ﹤0.01%
11
DEN
2880
DELISTED
Denbury Inc.
DEN
$1K ﹤0.01%
+13
New +$792
RAD
2881
DELISTED
Rite Aid Corporation
RAD
$1K ﹤0.01%
37
SURF
2882
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$1K ﹤0.01%
+137
New +$1.06K
ACGN
2883
DELISTED
Aceragen Inc
ACGN
$1K ﹤0.01%
+59
New +$1.19K
SQZ
2884
DELISTED
SQZ Biotechnologies Company
SQZ
$1K ﹤0.01%
+74
New +$967
USX
2885
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$1K ﹤0.01%
+105
New +$1.12K
ONCR
2886
DELISTED
Oncorus, Inc.
ONCR
$1K ﹤0.01%
+59
New +$911
SGTX
2887
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$1K ﹤0.01%
+7
New +$1.23K
CDAK
2888
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$1K ﹤0.01%
+42
New +$807
SRNE
2889
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$1K ﹤0.01%
77
IVC
2890
DELISTED
Invacare Corporation
IVC
$1K ﹤0.01%
128
EAR
2891
DELISTED
Eargo, Inc. Common Stock
EAR
$1K ﹤0.01%
+1
New +$838
CLVS
2892
DELISTED
Clovis Oncology, Inc.
CLVS
$1K ﹤0.01%
100
IPOD
2893
DELISTED
Social Capital Hedosophia Holdings Corp. IV
IPOD
$1K ﹤0.01%
100
IPOF
2894
DELISTED
Social Capital Hedosophia Holdings Corp. VI
IPOF
$1K ﹤0.01%
100
EPZM
2895
DELISTED
Epizyme, Inc
EPZM
$1K ﹤0.01%
134
BTNB
2896
DELISTED
Bridgetown 2 Holdings Limited Class A Ordinary Shares
BTNB
$1K ﹤0.01%
+100
New +$1.02K
MEUSW
2897
DELISTED
23andMe Holding Co Warrant
MEUSW
$1K ﹤0.01%
+333
New +$666
ITMR
2898
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
$1K ﹤0.01%
25
SKINW
2899
DELISTED
The Beauty Health Company Warrant expiring 5/4/2026
SKINW
$1K ﹤0.01%
+214
New +$918
KIN
2900
DELISTED
Kindred Biosciences, Inc.
KIN
$1K ﹤0.01%
+109
New +$634

Similar funds

Parallel Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Parallel Advisors held 3,215 positions worth $2.36B, up 11% from $2.12B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Parallel Advisors deployed $106M of net new capital in Q2 2021, opening 294 new positions and adding to 1,348 existing holdings. Its largest new stake was Dimensional US Core Equity 2 ETF: 118,367 shares worth $3.19M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares US Treasury Bond ETF, an estimated $8.53M trimmed.

  • Parallel Advisors's largest Q2 2021 buy was Dimensional US Core Equity 2 ETF: 118,367 shares worth $3.19M.
  • Parallel Advisors added most to State Street Energy Select Sector SPDR ETF in Q2 2021, an estimated $14.3M increase.
  • Parallel Advisors's biggest Q2 2021 reduction was iShares US Treasury Bond ETF, cutting an estimated $8.53M.
  • Parallel Advisors fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $365K.
  • Parallel Advisors's ten largest holdings make up 35% of its $2.36B portfolio in Q2 2021.
  • Parallel Advisors opened 294 new positions and closed 158 in Q2 2021.
  • Parallel Advisors's portfolio value rose 11% quarter-over-quarter to $2.36B.

Based on Parallel Advisors's 13F filing for Q2 2021, filed 6 Aug 2021.